13G Filing: Empery Asset Management, Lp and Aethlon Medical Inc (NASDAQ:AEMD)

This statement is filed by the entities and persons listed below,
who are collectively referred to herein as “Reporting Persons,” with respect to the shares of Common Stock (as
defined in Item 2(d) below) of the Company:

Investment Manager

(i)       Empery Asset Management,
LP (the “Investment Manager“), with respect to the shares of Common Stock held by, and underlying the Reported
Warrants (as defined below) held by, the funds to which the Investment Manager serves as investment manager (the “Empery
Funds“).

Reporting Individuals

(ii)       Mr. Ryan M. Lane (“Mr.
Lane“), with respect to the shares of Common Stock held by, and underlying the Reported Warrants held by, the Empery Funds.

(iii)       Mr. Martin D. Hoe
(“Mr. Hoe“), with respect to the shares of Common Stock held by, and underlying the Reported Warrants held by,
the Empery Funds.

The Investment Manager serves as the investment manager to each
of the Empery Funds. Each of the Mr. Lane and Mr. Hoe (the “Reporting Individuals“) is a Managing Member of Empery
AM GP, LLC (the “General Partner“), the general partner of the Investment Manager.

The address of the business office of each of the Reporting Persons
is:

1 Rockefeller Plaza, Suite 1205

New York, New York 10020